Similarly, MK-expressing melanoma tumors increased resistance to anti-PD1 and anti-PD-L1 antibodies by which Tregs and F4/80 macrophages, rather than cytotoxic CD8+ T cells, were recruited into the tumor site [33]. The gene discussed is PDCD1; the disease is neoplasm.